Investor profile
GIMV has backed 49 European tech companies across 70 funding rounds between 2005 and 2026, joining rounds totalling €1.3B. Most active in Healthtech and Software. Data as of 6 Aug 2026.
Also recorded as: Gimv
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Fire1 | Ireland | 3 | €179M |
| Precirix | Belgium | 1 | €80M |
| Immunos Therapeutics | Switzerland | 2 | €78M |
| Complement Therapeutics | Germany | 1 | €72M |
| Inside Secure | France |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Fire1 | Other | €115M | 2025-01 |
| Precirix | Series B | €80M | 2022-03 |
| Complement Therapeutics | Series A | €72M | 2023-04 |
| Immunos Therapeutics |
| 4 |
| €69M |
| Agrosavfe | Belgium | 4 | €59M |
| Spineart | Switzerland | 2 | €57M |
| Endosense | Switzerland | 2 | €56M |
| Exciva | Germany | 1 | €51M |
| Anjarium Biosciences | Switzerland | 1 | €51M |
| Breath Therapeutics | Germany | 1 | €44M |
| iSTAR Medical | Belgium | 1 | €40M |
| Camel-IDS | Belgium | 1 | €37M |
| Biom'Up | France | 1 | €31M |
| Onera Health | Netherlands | 1 | €30M |
| Itineris | Belgium | 3 | €27M |
| Onward | Netherlands | 1 | €27M |
| G-Therapeutics | Netherlands | 1 | €26M |
| Teads | France | 1 | €23M |
| Clear2Pay | Belgium | 2 | €22M |
| GreenPeak | Netherlands | 2 | €22M |
| Imcheck Therapeutics | France | 1 | €20M |
| Liquavista | Netherlands | 2 | €19M |
| Topas Therapeutics | Germany | 1 | €18M |
| Ebuzzing | UK | 1 | €18M |
| MarcoVasco (Planetveo) | France | 1 | €15M |
| Movea | France | 2 | €14M |
| McPhy | France | 1 | €14M |
| Equipe Zorgbedrijven | Netherlands | 1 | €13M |
| Real Impact Analytics | Luxembourg | 1 | €12M |
| Series B |
| €68M |
| 2022-06 |
| Exciva | Series B | €51M | 2026-01 |
| Anjarium Biosciences | Series A | €51M | 2021-09 |
| Breath Therapeutics | Series A | €44M | 2017-03 |
| Fire1 | Series C | €40M | 2018-01 |
| iSTAR Medical | Series C | €40M | 2019-07 |
| Camel-IDS | Series A | €37M | 2018-11 |
